Howard Urnovitz

Howard Urnovitz is the Chief Executive Officer at FBB Biomed since March 2020. Howard has a background in microbiology and immunology with various roles in founding and leading biomed companies like Chronix Biomedical and Calypte Biomedical. Prior to that, Howard had postdoctoral research roles at the University of Iowa and Washington University School of Medicine. Howard holds a PhD, MS, and BS in Microbiology and Immunology from the University of Michigan.